Literature DB >> 15913732

Sacral neuromodulation: long-term experience of one center.

Mostafa M Elhilali1, Sabri M Khaled, Takeshi Kashiwabara, Ehab Elzayat, Jacques Corcos.   

Abstract

OBJECTIVES: To perform a retrospective analysis of the long-term results of our experience with neuromodulation. Our center has been involved in the early studies leading to approval of the NeuroStim system of neuromodulation for the treatment of patients presenting with refractory lower urinary symptoms of urgency/frequency with or without incontinence and chronic urinary retention.
METHODS: A total of 52 patients have undergone implantation at our center since 1990 using very rigid criteria, including temporary percutaneous nerve evaluation for up to 7 days and a requirement of 50% improvement before consideration for implantation. Patients were followed up closely and a telephone questionnaire was conducted for those patients not seen in the previous 6 months. Of the 52 patients, 11 were not available for evaluation. Of the 41 remaining patients, 22 had urgency/frequency syndrome, 6 had urgency incontinence, 9 had urinary retention, and 4 had interstitial cystitis with intractable pelvic pain.
RESULTS: Of the 41 patients, 5 required explantation. These 5 patients were offered reimplantation but declined. Of the 22 patients in the urgency/frequency group, 10 (45%) had persistent improvement. In the urgency incontinence group, 3 of the 6 patients required explantation, and 1 (17%) reported improvement in the frequency of incontinence episodes. Of the 9 patients in the chronic urinary retention group, 7 (78%) had improvement.
CONCLUSIONS: The long-term (up to 13 years) results of neuromodulation in patients presenting with urgency/frequency with and without urge incontinence and urinary retention were reviewed. The long-term results in the first two groups were not maintained over time. The patients with chronic urinary retention, although a small sample, fared better.

Entities:  

Mesh:

Year:  2005        PMID: 15913732     DOI: 10.1016/j.urology.2004.12.016

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  The history of sacral neuromodulation in Canada.

Authors:  Jerzy B Gajewski; Magdy M Hassouna; Jacques Corcos; Gary J Gray; Le Mai Tu; Neil Dwyer
Journal:  Can Urol Assoc J       Date:  2020-04-01       Impact factor: 1.862

2.  A modified approach to patient's selection with improved clinical outcomes in sacral nerve modulation.

Authors:  Patrick Richard; Maude Carmel; Bechir Hage; Sophie Ramsay; Le Mai Tu
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

Review 3.  [Overactive bladder syndrome. Are there indications for surgical therapy?].

Authors:  J N Nyarangi-Dix; A Haferkamp; A Reitz; M Hohenfellner
Journal:  Urologe A       Date:  2006-10       Impact factor: 0.639

Review 4.  Neuromodulation for Management of Chronic Pelvic Pain: A Comprehensive Review.

Authors:  David Hao; Alp Yurter; Robert Chu; Mariam Salisu-Orhurhu; Henry Onyeaka; Jon Hagedorn; Kiran Patel; Ryan D'Souza; Susan Moeschler; Alan David Kaye; Vwaire Orhurhu
Journal:  Pain Ther       Date:  2022-09-15

5.  [Chronic pelvic pain syndrome: neurostimulation, neuromodulation and acupuncture].

Authors:  M Walter; U Sammer; T M Kessler
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

6.  Subcutaneous tunneling of the temporary testing electrode significantly improves the success rate of subchronic sacral nerve modulation (SNM).

Authors:  Karl-Dietrich Sievert; Udo Nagele; Juergen Pannek; Daniel Engeler; Markus Kuczyk; Arnulf Stenzl
Journal:  World J Urol       Date:  2007-10-03       Impact factor: 4.226

7.  Long-term outcome of sacral neuromodulation in patients with idiopathic nonobstructive urinary retention: Single-center experience.

Authors:  Shahbaz Mehmood; Waleed Mohammad Altaweel
Journal:  Urol Ann       Date:  2017 Jul-Sep

8.  Long-term Outcomes of Sacral Nerve Stimulation in Pelvic Floor Dysfunctions.

Authors:  David Hernández-Hernández; Bárbara Padilla-Fernández; Milagros Castro Romera; Stephany Hess Medler; David Castro-Díaz
Journal:  Int Neurourol J       Date:  2021-01-27       Impact factor: 2.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.